TAMPA, Fla., Oct. 27, 2021 /PRNewswire/ Keystone Heart Ltd., a Venus Medtech Company, today announced a key milestone in Europe with the TriGUARD 3 Cerebral Embolic Protection (CEP) Device.
TAMPA, Fla., Oct. 18, 2021 /PRNewswire/ Keystone Heart Ltd., a Venus Medtech Company, today celebrated an important achievement of treating 100 patients with the TriGUARD 3 Cerebral Embolic
TAMPA, Fla., Oct. 18, 2021 /PRNewswire/ Keystone Heart Ltd., a Venus Medtech Company, today celebrated an important achievement of treating 100 patients with the TriGUARD 3™ Cerebral Embolic Protection